Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2005
05/25/2005EP1532118A2 Imidazole compounds for the treatment of hepatitis c virus infections
05/25/2005EP1531864A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/25/2005EP1531861A2 Mycoplasma gallisepticum formulation
05/25/2005EP1531859A1 Compositions and methods for transepithelial molecular transport
05/25/2005EP1531854A2 O-derivatized nocathiacin derivatives
05/25/2005EP1531851A2 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
05/25/2005EP1531850A2 Use of il-21 in cancer and other therapeutic applications
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531843A1 Method for treating cervical cancer
05/25/2005EP1531841A1 Probiotics for gut neuromuscular functions
05/25/2005EP1531837A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
05/25/2005EP1531828A2 Methods of treating bacterial infections and diseases associated therewith
05/25/2005EP1531826A2 Prophylaxis and treatment of infectious diseases
05/25/2005EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors
05/25/2005EP1531808A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions
05/25/2005EP1531800A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
05/25/2005EP1531795A1 Formulations limiting spread of pulmonary infections
05/25/2005EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
05/25/2005EP1411908B1 Nitrogen oxide generating compositions for the treatment of subungual infections
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1287137B1 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1210131A4 Herb medicine composition to be spread on sanitary napkin for female
05/25/2005EP1165058B1 Azalide antibiotics for the topical treatment or prevention of ocular infections
05/25/2005EP1162992B1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
05/25/2005EP1161146B1 Deep penetrating antimicrobial compositions
05/25/2005EP1023320B1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005CN1620655A System and method for controlling user interface attribute by data
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620460A Crystalline hydrochloride of 7-(((5-amino-1, 2, 4-thiadiazol-3-yl)(fluoromethoxyimino) acetyl) amino) -3- ((imino-1-piperazinylmethyl)methylhydrazono)-methyl-3-cephem-4-carboxylic acid
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620414A 维生素d类似物 Vitamin d analogues
05/25/2005CN1620314A Gas micro-liposome compound
05/25/2005CN1620311A Therapeutic agent
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1620307A Anti-HIV agent
05/25/2005CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies
05/25/2005CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
05/25/2005CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients
05/25/2005CN1620281A Formulation & dosage form for the controlled delivery of therapeutic agents
05/25/2005CN1620280A 感染控制系统 Infection Control System
05/25/2005CN1618802A Tetramer combined with SARS antigen peptide and its preparation and use
05/25/2005CN1618800A Cyclic lactone antibiotic intermediate and its preparation
05/25/2005CN1618789A Macrocyclic peptides active against the hepatitis C virus
05/25/2005CN1618468A Series non-virus carrier, and medicinal composition contg. same
05/25/2005CN1618466A Vaccine for treating hepatitis B, and its prepn. method
05/25/2005CN1618465A 联合疫苗组合物 Combined vaccine composition
05/25/2005CN1618463A Composite prepns. for treating and preventing SARS
05/25/2005CN1618456A Traditional Chinese medicine pill for treating lockjaw, and its prescription
05/25/2005CN1618444A Composite biological liquor for cleaning toxins (or clearing lung and eliminating toxin biological liquor), and its prepn. method
05/25/2005CN1618436A Traditional Chinese medicine decoction for treating skin tinea
05/25/2005CN1618435A Oral liquor for promoting-blood circulation and removing blood stasis contg. Radix astragali and ginseng
05/25/2005CN1618430A Adefovir composite medicine for treating hepatitis B
05/25/2005CN1618428A Cefadroxil oral disintegrant tablet, and its prepn. method
05/25/2005CN1618427A Medicinal resin biological adhering slow-releasing liquid prepn. contg. aciclovir, and its prepn. method
05/25/2005CN1618425A Composition contg. theaflavin and its derivatives, prepn. method and application thereof
05/25/2005CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203093C Method for producing whole silkworm powder milk-containing and ferritin
05/25/2005CN1203090C Cyclic bonding inhibitor
05/25/2005CN1203089C New compound
05/25/2005CN1203084C Novel crystalline forms of macrolide antibiotic
05/25/2005CN1203062C Purification method of climbazole
05/25/2005CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient
05/25/2005CN1203055C Method and composition for treating or preventing bacterial infection
05/25/2005CN1202868C Bacterial medical nano suppository for woman and its preparing process
05/25/2005CN1202861C Use of compound interferon in treating SARS disease
05/25/2005CN1202860C Anti-SARS virus transfer factor preparation method
05/25/2005CN1202856C Medicine for treating AIDS and its prepn
05/25/2005CN1202852C Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof
05/25/2005CN1202851C Medicine for treating children's cold and its prepn process
05/25/2005CN1202836C Toad skin preparation and productive process thereof
05/25/2005CN1202834C Application of effective part of Chinese medicinal material lindley eupatorium herb in preparing antiviral medicine
05/25/2005CN1202831C Macrolide formulations for inhalation and use thereof
05/25/2005CN1202829C Pharmaceutical formulations
05/25/2005CN1202827C 皮肤搽剂 Skin liniments
05/25/2005CN1202824C Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for preparing medicine for treating hepatitis virus infection
05/25/2005CN1202820C Subprostrate sophora oral preparation, preparing method and use
05/25/2005CN1202736C Method for administering viable microorganism composition for poultry
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids
05/24/2005US6897233 Enzyme inhibitors, a 2-oxopyrrolidin-3-yl-N-hydroxyacetamide derivatives; bactericides
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897230 Bicyclo[3/1/0] hexane containing oxazolidinone antibiotics and derivatives thereof
05/24/2005US6897227 Prodrugs of proton pump inhibitors
05/24/2005US6897221 Urea substituted imidazoquinolines
05/24/2005US6897209 Thrombosis; anticholesterol agents; cardiovascular disorders; antiinflammatory agents; anticancer agents